Open Access

Research Article

Materials and Methods Top

Cell culture

Mouse epidermal JB6 Cl41 cells and their stable transfectants were cultured in Eagle’s minimal essential medium (MEM; Calbiochem, San Diego, CA) supplemented with 5% fetal bovine serum (FBS), 1% penicillin/streptomycin, and 2 mM L-glutamine (Life Technologies, Inc. Rockville, MD) at 37°C in a humidified atmosphere with 5% CO₂ in the air. To investigate the potential contribution of the NFκB transcription factor to COX-2 transcriptional induction by arsenite, we used COX-2-luciferase (COX-2-Luc) reporter containing full length (−1432/+59) or a mutation of the NFκB binding sites (−223/−214) of human COX-2 gene promoter linked to the luciferase (Subbaramaiah et al. 2001; Yan et al. 2000) and/or with IKKβ-KM as described previously (Ouyang et al. 2006). Wild-type and IKKβ knockout (IKKβ^−/−) mouse embryonic fibroblasts (MEFs) were cultured in Dulbecco’s modified Eagle’s medium (DMEM) containing 10% FBS, 1% penicillin/streptomycin, and 2 mM L-glutamine.

Construction of the siRNA vector

The specific small-interference RNA (siRNA)–targeted mouse COX-2 was designed using the siRNA converter of Ambion Inc. (2006a) according to the gene sequence in GenBank (mouse NM-011198, National Center for Biotechnology Information 2006b) and guidelines for siRNA (Ambion Inc. 2006b); the siRNA was synthesized by Invitrogen (Carlsbad, CA). The target sequence for mouse COX-2 was 5′-AGACAGATCATAAGCGAGGA-3′. The siRNA sequence was controlled via BLAST search (National Center for Biotechnology Information 2006a) and did not show any homology to other known genes. The siRNA was then inserted into pSuppressor vector and verified by DNA sequencing. The siRNA vector was designated as siCOX-2.

Stable transfection

Cl41 cells were transfected with either siCOX-2 or small-interference–green fluorescent protein. IKKβ^−/− MEFs were transfected with COX-2 expression vector, which was a gift from K. Subbaramaiah (Weill Medical College of Cornell University, New York, NY). The transfection was performed by Lipofectamine 2000 reagent (Gibco BRL, Rockville, MD) according to the manufacturer’s instructions. Briefly, the cells were cultured in a 6-well plate to 85–90% confluence. Five micrograms of plasmid DNA was mixed with 10 μL Lipofectamine 2000 reagent and then used to transfect each well in the absence of serum. After 4–6 hr, the medium was replaced with 5% FBS MEM for Cl41 cells or 10% FBS DMEM for MEFs. Approximately 36–48 hr after the beginning of the transfection, the cells were cultured with medium containing 500 μg/mL G418 (Gibco BRL). After selection for 28–45 days with G418, the stable transfectants were identified by Western blot. Stable transfectants, Cl41-mock, Cl41-siCOX-2, IKKβ^−/−(vector), and IKKβ^−/−(COX-2) were established and cultured in G418-free medium for at least two passages before each experiment.

COX-2 expression assay

We cultured 2 × 10⁵ Cl41 cells, IKKβ^−/− MEFs, and their transfectants in each well of 6-well plates to 70–80% confluence. After exposure to arsenite for indicated times, the cells were washed once with ice-cold phosphate-buffered saline (PBS) and then extracted with sodium dodecyl sulfate (SDS) sample buffer. The cell extracts (with GAPDH used as a control for protein loading) were separated on polyacrylamide-SDS gels, transferred, and probed with a rabbit-specific antibody against COX-2 (Cayman Chemical, Ann Arbor, MI). The protein band, specifically bound to the primary antibody, was detected using an anti-rabbit IgG-alkaline phosphatase-linked antibody and an enhanced chemifluorescence Western blotting system (Amersham Biosciences, Piscataway, NJ).

Cell apoptosis analysis by flow cytometry

Cells (2 × 10⁵) were seeded into each well of 6-well plates and cultured to 70–80% confluence. After exposure to arsenite, the cells were harvested and fixed with 3 mL ice-cold 80% ethanol overnight. The fixed cells were washed twice with PBS and then suspended in propidium iodide (PI) staining solution (50 μg/mL PI, 10 mg/mL RNase A) (Sigma Chemical, St. Louis, MO) for at least 1 hr at 4°C. Cell apoptosis was determined by flow cytometry using the Epics XL FACS and EXPO 32 software (Beckman Coulter, Miami, FL) as described previously (Ouyang et al. 2006).

TUNEL assay

We performed the TUNEL assay using an in situ cell death detection kit (Roche Applied Science, Indianapolis, IN) following the kit instructions. Briefly, the exposed cells were fixed by 4% polyparaformaldehyde solution in PBS for 24 hr at room temperature. After rinsing with PBS, the cells were resuspended in a solution with 0.1% Triton X-100 and 0.1% sodium citrate for 5 min to increase permeability of the cell membrane, and then incubated with 50 μL TUNEL reaction mixture containing terminal deoxynucleotidyl transferase (TdT) and fluorescein isothiocyanate-deoxyuridine triphosphate (FITC-dUTP) for 60 min at 37°C. After washing, the label incorporated at the damaged sites of the DNA was visualized by flow cytometry using the Epics XL FACS and EXPO 32 software.

Results Top

Arsenite exposure induced COX-2 expression in Cl41 cells through the IKKβ/NFκB pathway

Previous studies demonstrated that arsenite exerts its carcinogenic effect mainly by activating signal pathways and inducing gene expression involved in the regulation of cell proliferation and apoptosis (Huang et al. 2004; Pi et al. 2005; Rossman 2003; Yang and Frenkel 2002). COX-2, a key inducible enzyme in the biosynthesis of prostaglandins, has been related to inflammation, apoptosis, and carcinogenesis (Liu et al. 1998; Tsujii and DuBois 1995; Tsujii et al. 1997, 1998). To determine whether COX-2 is also involved in cell response to arsenite exposure, we examined COX-2 induction by arsenite in mouse epidermal Cl41 cells. As determined by Western blot analysis (Figure 1A), arsenite exposure caused a significant elevation of COX-2 protein level. Moreover, Cl41 cells exposed to arsenite for 12 hr showed a marked induction of COX-2 transcription in the gene reporter assay (Figure 1B).

The promoter region of the COX-2 gene contains a canonical TATA box and multiple putative transcriptional regulatory elements, including NFκB, which has been indicated to be activated in Cl41 cells by arsenite exposure (Li et al. 2004). We investigated the potential contribution of the NFκB transcription factor to COX-2 transcriptional induction by arsenite using the COX-2-Luc reporter containing full length (−1432/+59) or mutant NFκB binding sites (−223/−214) of the COX-2 gene promoter. As shown in Figure 1C, deletion of NFκB binding sites impaired arsenite-induced COX-2 transcriptional induction. Moreover, the stable transfectants of Cl41 cells harboring IKKβ-KM, a dominant mutant of IKKβ (Ouyang et al. 2006), and IKKβ^−/− MEFs were used to further confirm the requirement of the IKKβ/NFκB pathway for the induction of COX-2 by arsenite. Arsenite-induced COX-2 expression was dramatically inhibited in the IKKβ-KM-transfected Cl41 cells, as well as in IKKβ^−/− MEFs, when compared with control vector-transfected Cl41 cells or wild-type MEFs (Figure 1D, E). The basal level of COX-2 varied at different time points, which might be due to cell cycle progression (Figure 1D, E). Collectively, these results indicate that arsenite can induce COX-2 expression at both protein and transcription levels via an IKKβ/NFκB–dependent pathway, suggesting that COX-2 is involved in cell response to arsenite exposure.

COX-2 induction through the IKKβ/NFκB pathway exerted an antiapoptotic effect on cells exposed to arsenite

In view of the importance of COX-2 in the regulation of cell apoptotic response in some cells, we proposed that the induction of COX-2 may also be implicated in the regulation of cell apoptosis upon arsenite exposure. Based on the above results that the IKKβ/NFκB pathway was required for COX-2 induction in the cells exposed to arsenite, we examined the apoptosis of Cl41 cells transfected with IKKβ-KM after the exposure to arsenite. The results obtained from microscopic observation of cell morphology (Figure 2A), DNA content analysis by PI staining followed by flow cytometry analysis (Figure 2B), and DNA fragment detection by TUNEL assay followed by flow cytometry analysis (Figure 2C) showed that the transfection of IKKβ-KM made Cl41 cells much more sensitive to apoptotic induction by arsenite. To confirm the importance of COX-2 in the regulation of apoptotic response after arsenite exposure, we pretreated Cl41 cells with NS398, an inhibitor of COX-2, and found that it significantly sensitized the cells to arsenite-induced cell apoptosis (Figure 3A, B), suggesting that COX-2 may be the mediator responsible for the antiapoptotic effect. This notion was further confirmed by the finding that knockdown of endogenous COX-2 expression by its specific siRNA rendered Cl41 cells much more susceptible to cell apoptotic induction by arsenite (Figure 3C, D).

The role of COX-2 induction in protecting cells from apoptosis after arsenite exposure was further verified by the finding that over-expression of COX-2 in IKKβ^−/− MEFs made the cells much more resistant to arsenite-induced apoptosis (Figure 4). Collectively, these results demonstrate that COX-2 induction through the IKKβ/NFκB pathway can protect arsenite-exposed cells from apoptosis.

Discussion Top

Arsenite is a well-documented skin carcinogen (Landolph 1994; Nriagu 2002); skin lesions, including skin cancers, are characteristic of exposure to arsenite in drinking water (Haque et al. 2003). Given the low genotoxic activity, arsenite is thought to exert its carcinogenic effect mainly through inducing activation of signal pathways, which thereby affects the expression of genes involved in regulating the machineries of the cell cycle and apoptosis (Huang et al. 2004; Pi et al. 2005; Rossman 2003; Yang and Frenkel 2002). In the present study, we have addressed the events involved in the regulation of apoptosis of cells exposed to arsenite, and demonstrated that induction of COX-2 expression through the IKKβ/NFκB pathway plays a role in antagonizing cell apoptosis caused by arsenite in mouse epidermal Cl41 cells.

The effect of arsenite on COX-2 expression depends on cell type and arsenite dosage. Arsenite stimulates COX-2 expression in endothelial cells through activating IKK/NFκB and extracellular signal–regulated kinases, respectively (Trouba and Germolec 2004; Tsai et al. 2002), whereas in a recent study, Ding et al. (2006) found that arsenite induces COX-2 expression in human bronchial epithelial Beas-2B cells through NFAT (nuclear factor of activated T cells) rather than NFκB and activator protein-1. Arsenite has been demonstrated to repress constitutive activation of NFκB and COX-2 expression in human acute myeloid leukemia (HL-60) cells (Han et al. 2005), and pretreatment of arsenite attenuates benzo[a]pyrene cytotoxicity in a human lung adenocarcinoma cells by decreasing cyclooxygenase-2 levels (Ho and Lee 2002). In the present study, we provide the first evidence that arsenite can induce COX-2 expression through the IKKβ/NFκB pathway in mouse epidermal Cl41 cells.

Although the detailed mechanisms underlying tumorigenesis remain largely undefined, it is generally accepted that apoptosis evasion is one of the hallmarks during cancer development (Hanahan and Weinberg 2000). Apoptosis plays a major role in developmental biology, cellular population dynamics, and disease states. Apoptosis typically occurs when cellular genetic damage exceeds the repair capacity. The suppression of apoptosis, in the face of significant genetic damage, could facilitate accumulation of aberrant cells and may be a critical step in the pathogenesis of malignancy (Abrams 2002; Johnstone et al. 2002; Zornig et al. 2001). As a sensor of cellular stress, p53 is a critical initiator of the apoptotic pathway (Lowe and Lin 2000). p53 protein accumulates in cells under stress, which thereby promotes apoptosis mainly by activating the expression of proapoptotic Bcl-2 family members (e.g., Bax, Bak, PUMA, Noxa) and repressing antiapoptotic Bcl-2 (B-cell leukemia) proteins (Bcl-2, Bcl-XL) and inhibitor of apoptosis protein (survivin) (Bartke et al. 2001; Hoffman et al. 2002; Ryan et al. 2001; Wu et al. 2001). The elimination of these damaged cells through apoptosis maintains genomic stability and prevents tumorigenesis. Because p53 mediates cell apoptosis and growth arrest, p53 mutation is responsible for > 50% of cancer development in humans. In the present study, we demonstrated that COX-2 plays an important role in antagonizing cell apoptosis induced by arsenite in mouse epidermal cells. Although a large body of evidence indicates the importance of COX-2 in the regulation of cell apoptosis, the mechanisms are not well-defined. Nonetheless, there is evidence supporting that COX-2 may interfere with p53-mediated cell apoptosis (Han et al. 2002) and regulate mitochondrial-triggered cell apoptosis (Sun et al. 2002). Although the exact mechanisms require further investigation, the antiapoptotic effect of COX-2 observed in the present study may provide more strategies with COX-2 as the target for skin cancer prevention and skin cancer therapy, especially in those countries with high arsenite contamination in drinking water.

It is notable that the contributions of the IKKs/NFκB pathway to carcinogen- induced skin cancer remain controversial. IKKα has been demonstrated to be an inhibitory factor for the proliferation of skin epidermis (Hu et al. 1999, 2001; Li et al. 1999) and over-expression of active p50 and p65 NFκB subunits in transgenic epithelium-produced hypoplasia and growth inhibition (Seitz et al. 1998). However, it has been reported that the deletion of IKKβ does not affect the proliferation of skin epidermis (Pasparakis et al. 2002); IκBα deficiency results in a sustained NFκB response and severe widespread dermatitis characterized by epidermal hyperplasia in mice (Klement et al. 1996). Budunova et al. (1999) demonstrated that epidermal inflammation and hyperplasia play a critical role in skin tumor promotion, and NFκB is one of the well-known mediators of these effects. Substances such as phorbol ester and okadaic acid, which are promoters of skin cancer, are also strong inducers of the NFκB response in keratinocytes (Budunova et al. 1999). In the present study, we demonstrated that the IKKβ/NFκB pathway is required for COX-2 induction by arsenite, suggesting that the IKKβ/NFκB pathway may contribute to arsenite-induced carcinogenesis by protecting cells from apoptosis through inducing COX-2 expression. Interestingly, we also found that apoptosis of IKKβ^−/− MEFs induced by arsenite is affected largely by cell density. High density of IKKβ^−/− MEFs shows much lower susceptibility to arsenite-induced apoptosis (Song et al. 2006). The mechanisms are now under investigation in our laboratory.

In summary, we have demonstrated that exposure of the cells to arsenite causes a significant COX-2 expression in an IKKβ/NFκB–dependent manner, which thereby plays an important role in antagonizing apoptosis induced by arsenite. These results suggest that arsenite, as a carcinogen, may facilitate skin cancer development by supporting the survival of the cells with genetic alterations, which is usually eliminated by apoptosis. Thus, inhibition of COX-2 may be a promising approach for skin cancer prevention in those countries with severe arsenite pollution in drinking water.

Figures Top

Figure 1.

COX-2 expression induced by arsenite exposure through the IKKβ/NFκB pathway. (A) C141 cells were treated with various concentrations of arsenite as indicated for 12 hr, extracted, and then analyzed by Western blot with specific antibodies against COX-2 or GAPDH, as described in “Materials and Methods.” (B, C) Relative COX-2 induction (activity relative to control) in Cl41 cells treated with 40 μM arsenite for 12 hr (B) and stably transfected with COX-2-Luc reporter containing full length (−1432/+59) or mutation of the NFκB binding sites (−223/−214) of the human COX-2 gene promoter linked to luciferase (C); each bar indicates the mean ± SD of triplicate wells. (D, E) Cl41 cells transfected with control vector or IKKβ-KM (D) or wild-type MEFs and IKKβ^−/− MEFs (E) were exposed to arsenite for 12 or 24 hr and then subjected to Western blot assay.

*Significant increase compared with medium control. **Significant decrease compared with intact COX-2 luciferase induction (p < 0.01).

Figure 2.

Transfection of IKKβ-KM increased the susceptibility of Cl41 cells to arsenite-induced cell apoptosis. C141-vector and Cl41-IKKβ-KM cells were treated with arsenite for 24 hr and photographed under microscopy (A). Cell apoptosis was analyzed using either PI staining (B) or the TUNEL assay (C) followed by flow cytometry analysis. (B) and (C) show representative results of three independent experiments; the numbers indicate the percentage of cells in sub-G₁ phase (B) and the percentage of cells with positive TUNEL staining (C).

Figure 3.

COX-2 induction is required for the protection of Cl41 cells from apoptosis after arsenite exposure. Cl41 cells were pretreated with 50 μM NS398 for 0.5 hr, treated with 20 μM arsenite for 48 hr, and photographed under microscopy (A); cell apoptosis was then analyzed by PI staining (B). (C) C141-mock vector and Cl41-siCOX-2 cells were exposed to 20 μM arsenite for 12 hr and then extracted with SDS-sample buffer; the cell extracts were analyzed by Western blot with antibodies against COX-2 or GAPDH. (D) C141-mock vector and Cl41-siCOX-2 cells were treated with arsenite for 36 hr, and cell apoptosis was analyzed using PI staining followed by flow cytometry analysis. Numbers in (B) and (D) indicate the percentage of cells in sub-G₁ phase.

Figure 4.

IKKβ^−/− MEFs overexpressing COX-2 acquired resistance to arsenite-induced cell apoptosis. (A) IKKβ^−/−(vector) and IKKβ^−/−(COX-2) cells were extracted with SDS-sample buffer, and the cell extracts were analyzed by Western blot with antibodies against COX-2 or GAPDH. (B, C) IKKβ^−/−(vector) and IKKβ^−/−(COX-2) were treated with 20 μM arsenite for 36 hr and photographed under microscopy (B); the cell apoptosis was analyzed using PI staining followed by flow cytometry analysis (C). Numbers in (C) indicate the percentage of cells in sub-G₁ phase.

References Top

1. Abrams JM 2002. Competition and compensation: coupled to death in development and cancer Cell 110(4):403–406. Find this article online
2. Ambion Inc 2006a. siRNA Target Finder. Available: http://www.ambion.com/techlib/misc/siRNA​_finder.html [accessed 15 February 2007]
3. Ambion Inc 2006b. siRNA Design Guidelines. Available: http://www.ambion.com/techlib/tb/tb_506.​html [accessed 15 February 2007]
4. Bartke T, Siegmund D, Peters N, Reichwein M, Henkler F, Scheurich P, et al. 2001. p53 upregulates cFLIP, inhibits transcription of NF-κB-regulated genes and induces caspase-8-independent cell death in DLD-1 cells Oncogene 20(5):571–580. Find this article online
5. Bettley FR, O’Shea JA 1975. The absorption of arsenic and its relation to carcinoma Br J Dermatol 92(5):563–568. Find this article online
6. Budunova IV, Perez P, Vaden VR, Spiegelman VS, Slaga TJ, Jorcano JL 1999. Increased expression of p50-NF-κB and constitutive activation of NF-κB transcription factors during mouse skin carcinogenesis Oncogene 18(52):7423–7431. Find this article online
7. Ding J, Li J, Xue C, Wu K, Ouyang W, Zhang D, et al. 2006. Cyclooxygenase-2 Induction by arsenite is through a nuclear factor of activated T-cell-dependent pathway and plays an antiapoptotic role in Beas-2B cells J Biol Chem 281(34):24405–24413. Find this article online
8. Feng L, Sun W, Xia Y, Tang WW, Chanmugam P, Soyoola E, et al. 1993. Cloning two isoforms of rat cyclooxygenase: differential regulation of their expression Arch Biochem Biophys 307(2):361–368. Find this article online
9. Fischer SM, Lo HH, Gordon GB, Seibert K, Kelloff G, Lubet RA, et al. 1999. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis Mol Carcinog 25(4):231–240. Find this article online
10. Han JA, Kim JI, Ongusaha PP, Hwang DH, Ballou LR, Mahale A, et al. 2002. P53-mediated induction of Cox-2 counteracts p53- or genotoxic stress-induced apoptosis Embo J 21(21):5635–5644. Find this article online
11. Han SS, Kim K, Hahm ER, Park CH, Kimler BF, Lee SJ, et al. 2005. Arsenic trioxide represses constitutive activation of NF-κB and COX-2 expression in human acute myeloid leukemia, HL-60 J Cell Biochem 94(4):695–707. Find this article online
12. Hanahan D, Weinberg RA 2000. The hallmarks of cancer Cell 100(1):57–70. Find this article online
13. Haque R, Mazumder DN, Samanta S, Ghosh N, Kalman D, Smith MM, et al. 2003. Arsenic in drinking water and skin lesions: dose-response data from West Bengal, India Epidemiology 14(2):174–182. Find this article online
14. Hecker E 1987. Three stage carcinogenesis in mouse skin—recent results and present status of an advanced model system of chemical carcinogenesis Toxicol Pathol 15(2):245–258. Find this article online
15. Hickman JA 2002. Apoptosis and tumourigenesis Curr Opin Genet Dev 12(1):67–72. Find this article online
16. Ho IC, Lee TC 2002. Arsenite pretreatment attenuates benzo[a]-pyrene cytotoxicity in a human lung adenocarcinoma cell line by decreasing cyclooxygenase-2 levels J Toxicol Environ Health A 65(3–4):245–263. Find this article online
17. Hoffman WH, Biade S, Zilfou JT, Chen J, Murphy M 2002. Transcriptional repression of the anti-apoptotic survivin gene by wild type p53 J Biol Chem 277(5):3247–3257. Find this article online
18. Hu Y, Baud V, Delhase M, Zhang P, Deerinck T, Ellisman M, et al. 1999. Abnormal morphogenesis but intact IKK activation in mice lacking the IKKα subunit of IκB kinase Science 284(5412):316–320. Find this article online
19. Hu Y, Baud V, Oga T, Kim KI, Yoshida K, Karin M 2001. IKKα controls formation of the epidermis independently of NF-κ B Nature 410(6829):710–714. Find this article online
20. Huang C, Ke Q, Costa M, Shi X 2004. Molecular mechanisms of arsenic carcinogenesis Mol Cell Biochem 255(1–2):57–66. Find this article online
21. IARC (International Agency for Research on Cancer) 1980. Some Metals and Metallic Compounds IARC Monogr Eval Carcinog Risk Chem Man 23:1–438. Find this article online
22. Johnstone RW, Ruefli AA, Lowe SW 2002. Apoptosis: a link between cancer genetics and chemotherapy Cell 108(2):153–164. Find this article online
23. Klement JF, Rice NR, Car BD, Abbondanzo SJ, Powers GD, Bhatt PH, et al. 1996. IκBα deficiency results in a sustained NF-κB response and severe widespread dermatitis in mice Mol Cell Biol 16(5):2341–2349. Find this article online
24. Krysan K, Reckamp KL, Dalwadi H, Sharma S, Rozengurt E, Dohadwala M, et al. 2005. Prostaglandin E₂ activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner Cancer Res 65(14):6275–6281. Find this article online
25. Landolph JR 1994. Molecular mechanisms of transformation of C3H/10T1/2 C1 8 mouse embryo cells and diploid human fibroblasts by carcinogenic metal compounds Environ Health Perspect 102(suppl 3):119–125. Find this article online
26. Li J, Chen H, Ke Q, Feng Z, Tang MS, Liu B, et al. 2004. Differential effects of polycyclic aromatic hydrocarbons on transactivation of AP-1 and NF-κB in mouse epidermal cl41 cells Mol Carcinog 40(2):104–115. Find this article online
27. Li Q, Lu Q, Hwang JY, Buscher D, Lee KF, Izpisua-Belmonte JC, et al. 1999. IKK1-deficient mice exhibit abnormal development of skin and skeleton Genes Dev 13(10):1322–1328. Find this article online
28. Liu XH, Yao S, Kirschenbaum A, Levine AC 1998. NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells Cancer Res 58(19):4245–4249. Find this article online
29. Lowe SW, Lin AW 2000. Apoptosis in cancer Carcinogenesis 21(3):485–495. Find this article online
30. National Center for Biotechnology Information 2006a. BLAST (Basic Local Alignment Search Tool). Available: http://www.ncbi.nlm.nih.gov/BLAST/ [accessed 15 February 2007]
31. National Center for Biotechnology Information 2006b. GenBank. Available: http://www.ncbi.nlm.nih.gov/Genbank/inde​x.html [accessed 15 February 2007]
32. National Research Council 1999. Arsenic in Drinking Water. Washington, DC:National Academy Press
33. Nriagu JO 2002. Environmental Chemistry of Arsenic. New York:Dekker
34. Ouyang W, Li J, Ma Q, Huang C 2006. Essential roles of PI-3K/Akt/IKKβ/NFκB pathway in cyclin D1 induction by arsenite in JB6 Cl41 cells Carcinogenesis 27(4):864–873. Find this article online
35. Pasparakis M, Courtois G, Hafner M, Schmidt-Supprian M, Nenci A, Toksoy A, et al. 2002. TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2 Nature 417(6891):861–866. Find this article online
36. Pi J, He Y, Bortner C, Huang J, Liu J, Zhou T, et al. 2005. Low level, long-term inorganic arsenite exposure causes generalized resistance to apoptosis in cultured human keratinocytes: potential role in skin co-carcinogenesis Int J Cancer 116(1):20–26. Find this article online
37. Rossman TG 2003. Mechanism of arsenic carcinogenesis: an integrated approach Mutat Res 533(1–2):37–65. Find this article online
38. Ryan KM, Phillips AC, Vousden KH 2001. Regulation and function of the p53 tumor suppressor protein Curr Opin Cell Biol 13(3):332–337. Find this article online
39. Seitz CS, Lin Q, Deng H, Khavari PA 1998. Alterations in NF-κB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-κB Proc Natl Acad Sci USA 95(5):2307–2312. Find this article online
40. Sheng H, Shao J, Washington MK, DuBois RN 2001. Prostaglandin E₂ increases growth and motility of colorectal carcinoma cells J Biol Chem 276(21):18075–18081. Find this article online
41. Smith WL, Garavito RM, DeWitt DL 1996. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2 J Biol Chem 271(52):33157–33160. Find this article online
42. Song L, Li J, Zhang D, Liu ZG, Ye J, Zhan Q, et al. 2006. IKKβ programs to turn on the GADD45α–MKK4–JNK apoptotic cascade specifically via p50 NF-κB in arsenite response J Cell Biol 175(4):607–617. Find this article online
43. Subbaramaiah K, Bulic P, Lin Y, Dannenberg AJ, Pasco DS 2001. Development and use of a gene promoter-based screen to identify novel inhibitors of cyclooxygenase-2 transcription J Biomol Screen 6(2):101–110. Find this article online
44. Sun Y, Tang XM, Half E, Kuo MT, Sinicrope FA 2002. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells Cancer Res 62(21):6323–6328. Find this article online
45. Tiano HF, Loftin CD, Akunda J, Lee CA, Spalding J, Sessoms A, et al. 2002. Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis Cancer Res 62(12):3395–3401. Find this article online
46. Trouba KJ, Germolec DR 2004. Micromolar concentrations of sodium arsenite induce cyclooxygenase-2 expression and stimulate p42/44 mitogen-activated protein kinase phosphorylation in normal human epidermal keratinocytes Toxicol Sci 79(2):248–257. Find this article online
47. Tsai SH, Liang YC, Chen L, Ho FM, Hsieh MS, Lin JK 2002. Arsenite stimulates cyclooxygenase-2 expression through activating IκB kinase and nuclear factor κB in primary and ECV304 endothelial cells J Cell Biochem 84(4):750–758. Find this article online
48. Tseng WP, Chu HM, How SW, Fong JM, Lin CS, Yeh S 1968. Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan J Natl Cancer Inst 40(3):453–463. Find this article online
49. Tsujii M, DuBois RN 1995. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2 Cell 83(3):493–501. Find this article online
50. Tsujii M, Kawano S, DuBois RN 1997. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential Proc Natl Acad Sci USA 94(7):3336–3340. Find this article online
51. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN 1998. Cyclooxygenase regulates angiogenesis induced by colon cancer cells Cell 93(5):705–716. Find this article online
52. Wang D, Buchanan FG, Wang H, Dey SK, DuBois RN 2005. Prostaglandin E₂ enhances intestinal adenoma growth via activation of the Ras-mitogen-activated protein kinase cascade Cancer Res 65(5):1822–1829. Find this article online
53. Wu Y, Mehew JW, Heckman CA, Arcinas M, Boxer LM 2001. Negative regulation of bcl-2 expression by p53 in hematopoietic cells Oncogene 20(2):240–251. Find this article online
54. Yan Z, Subbaramaiah K, Camilli T, Zhang F, Tanabe T, McCaffrey TA, et al. 2000. Benzo[a]pyrene induces the transcription of cyclooxygenase-2 in vascular smooth muscle cells. Evidence for the involvement of extracellular signal-regulated kinase and NF-κB J Biol Chem 275(7):4949–4955. Find this article online
55. Yang C, Frenkel K 2002. Arsenic-mediated cellular signal transduction, transcription factor activation, and aberrant gene expression: implications in carcinogenesis J Environ Pathol Toxicol Oncol 21(4):331–342. Find this article online
56. Yu HS, Liao WT, Chai CY 2006. Arsenic carcinogenesis in the skin J Biomed Sci 13(5):657–666. Find this article online
57. Zornig M, Hueber A, Baum W, Evan G 2001. Apoptosis regulators and their role in tumorigenesis Biochim Biophys Acta 1551(2):F1–37. Find this article online
58. Zoumpourlis V, Solakidi S, Papathoma A, Papaevangeliou D 2003. Alterations in signal transduction pathways implicated in tumour progression during multistage mouse skin carcinogenesis Carcinogenesis 24(7):1159–1165. Find this article online